Gossamer Bio, Inc. (GOSS)
10.11
-0.67
(-6.22%)
USD |
NASDAQ |
Oct 07, 16:00
10.30
+0.19
(+1.88%)
After-Hours: 20:00
Gossamer Bio Market Cap : 61.78M for Oct. 7, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 06, 2026 | 65.87M |
| October 05, 2026 | 65.08M |
| October 02, 2026 | 65.44M |
| October 01, 2026 | 66.79M |
| September 30, 2026 | 72.41M |
| September 29, 2026 | 70.76M |
| September 28, 2026 | 70.39M |
| September 25, 2026 | 66.85M |
| September 24, 2026 | 66.79M |
| September 23, 2026 | 67.16M |
| September 22, 2026 | 71.43M |
| September 21, 2026 | 68.93M |
| September 18, 2026 | 65.57M |
| September 17, 2026 | 72.96M |
| September 16, 2026 | 66.97M |
| September 15, 2026 | 63.43M |
| September 14, 2026 | 65.38M |
| September 11, 2026 | 65.57M |
| September 10, 2026 | 69.61M |
| September 09, 2026 | 78.07M |
| September 08, 2026 | 87.94M |
| September 04, 2026 | 6.856B |
| September 03, 2026 | 6.867B |
| September 02, 2026 | 6.754B |
| September 01, 2026 | 6.547B |
| Date | Value |
|---|---|
| August 31, 2026 | 6.648B |
| August 28, 2026 | 6.652B |
| August 27, 2026 | 6.652B |
| August 26, 2026 | 6.801B |
| August 25, 2026 | 7.998B |
| August 24, 2026 | 6.844B |
| August 21, 2026 | 6.050B |
| August 20, 2026 | 6.159B |
| August 19, 2026 | 6.124B |
| August 18, 2026 | 5.596B |
| August 17, 2026 | 5.475B |
| August 14, 2026 | 6.030B |
| August 13, 2026 | 6.660B |
| August 12, 2026 | 6.946B |
| August 11, 2026 | 7.110B |
| August 10, 2026 | 6.887B |
| August 07, 2026 | 6.961B |
| August 06, 2026 | 6.977B |
| August 05, 2026 | 6.949B |
| August 04, 2026 | 7.098B |
| August 03, 2026 | 6.789B |
| July 31, 2026 | 6.629B |
| July 30, 2026 | 6.973B |
| July 29, 2026 | 8.084B |
| July 28, 2026 | 8.021B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| United Therapeutics Corp. | 23.25B |
| Arbutus Biopharma Corp. | 845.87M |
| Kura Oncology, Inc. | 948.69M |
| ACADIA Pharmaceuticals, Inc. | 3.382B |
| Alnylam Pharmaceuticals, Inc. | 30.02B |
Market Cap Related Metrics
| PS Ratio | 0.6033 |
| PEG Ratio | -0.0132 |
| Price | 10.11 |
| Earnings Yield | -550.6% |
| PEGY Ratio | -0.0132 |